Inozyme Pharma, Inc. (NASDAQ:INZY) COO Henric Bjorn Bjarke Purchases 27,100 Shares

Inozyme Pharma, Inc. (NASDAQ:INZY – Get Rating) COO Henric Bjorn Bjarke bought 27,100 shares of the firm’s stock in a transaction that occurred on Tuesday, April 19th. The stock was bought at an average price of $3.69 per share, with a total value of $99,999.00. Following the completion of the acquisition, the chief operating officer […]

Related Keywords

Inozyme Pharma ,Thomson Reuter ,Henric Bjorn Bjarke ,Inozyme Pharma Company Profile Get Rating ,Inozyme Pharma Inc ,Zacks Investment Research ,Nasdaq ,Needham Company ,Marshall Wace ,Wells Fargo Company ,Walleye Capital ,Millennium Management ,Get Rating ,Bjorn Bjarke ,Investment Research ,Adage Capital Partners ,Capital Partners ,Pharma Company Profile ,Nasdaq Inzy ,Minzy ,Medical ,Insider Trading ,Nsider Trades ,Stocks ,